Ezrin expression in breast cancer (Wang et al., 2009), endometrial cancer (Ohtani et al., 1999), uterine cancer (Kobel et al., 2006), uveal melanoma (Ilmonen, Vaheri, Asko‐Seljavaara, & Carpen, 2005), and soft tissue sarcoma (Weng, Ahlén, Aström, Lui, & Larsson, 2005) is associated with low survival rate. Here, EZR is linked to uveal melanoma.